IO Biotech

Investment area
Novo Seeds
Region
Europe
Date of investment
January 2014

IO Biotech is a clinical stage biotech company developing distruptive immune therapies for immunological treatment of cancer.

IO Biotech

Investment area
Novo Seeds
Region
Europe
Date of investment
January 2014

IO Biotech is a clinical stage biotech company developing distruptive immune therapies for immunological treatment of cancer.

IO Biotech

Investment area
Novo Seeds
Region
Europe
Date of investment
January 2014

IO Biotech is a clinical stage biotech company developing distruptive immune therapies for immunological treatment of cancer.